Client News

Roquefort Therapeutics plc: Appointment of Auditor
Home / Client News / Roquefort Therapeutics plc: Appointment of Auditor

Roquefort Therapeutics (LSE:ROQ, OTCQB:ROQAF), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth oncology market, announces that it has appointed BDO LLP as its auditors with immediate effect.  The appointment of BDO LLP will be subject to approval by shareholders at the next Annual General Meeting of the Company.


If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.


Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.

Share This